Mortensen DL - Search Results

1

Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.

Dubaquié Y, Mortensen DL, Intintoli A, Hogue DA, Nakamura G, Rancatore P, Lester P, Sadick MD, Filvaroff E, Fielder PJ, Lowman HB. Dubaquié Y, et al. Among authors: mortensen dl. Endocrinology. 2001 Jan;142(1):165-73. doi: 10.1210/endo.142.1.7864. Endocrinology. 2001. PMID: 11145579

2

Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.

Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Fielder PJ, et al. Among authors: mortensen dl. Endocrinology. 1996 May;137(5):1913-20. doi: 10.1210/endo.137.5.8612531. Endocrinology. 1996. PMID: 8612531

3

Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.

Lowman HB, Chen YM, Skelton NJ, Mortensen DL, Tomlinson EE, Sadick MD, Robinson IC, Clark RG. Lowman HB, et al. Among authors: mortensen dl. Biochemistry. 1998 Jun 23;37(25):8870-8. doi: 10.1021/bi980426e. Biochemistry. 1998. PMID: 9636028

4

Insulin-like growth factor binding protein-1 induces insulin release in the rat.

Mortensen DL, Won WB, Siu J, Reifsnyder D, Gironella M, Etcheverry T, Clark RG. Mortensen DL, et al. Endocrinology. 1997 May;138(5):2073-80. doi: 10.1210/endo.138.5.5143. Endocrinology. 1997. PMID: 9112407

5

Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies.

Mortensen DL, Prabhu S, Stefanich EG, Kadkhodayan-Fischer S, Gelzleichter TR, Baker D, Jiang J, Wallace K, Iyer S, Fielder PJ, Putnam WS. Mortensen DL, et al. MAbs. 2012 Nov-Dec;4(6):724-31. doi: 10.4161/mabs.22216. MAbs. 2012. PMID: 23778267 Free PMC article.

6

The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.

Clark RG, Mortensen DL, Carlsson LM, Carlsson B, Carmignac D, Robinson IC. Clark RG, et al. Among authors: mortensen dl. Endocrinology. 1996 May;137(5):1904-12. doi: 10.1210/endo.137.5.8612530. Endocrinology. 1996. PMID: 8612530

7

Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.

Clark RG, Mortensen DL, Carlsson LM, Spencer SA, McKay P, Mulkerrin M, Moore J, Cunningham BC. Clark RG, et al. Among authors: mortensen dl. Endocrinology. 1996 Oct;137(10):4308-15. doi: 10.1210/endo.137.10.8828490. Endocrinology. 1996. PMID: 8828490

8

Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?

Deng R, Iyer S, Theil FP, Mortensen DL, Fielder PJ, Prabhu S. Deng R, et al. Among authors: mortensen dl. MAbs. 2011 Jan-Feb;3(1):61-6. doi: 10.4161/mabs.3.1.13799. Epub 2011 Jan 1. MAbs. 2011. PMID: 20962582 Free PMC article.

9

Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.

Clark RG, Thomas GB, Mortensen DL, Won WB, Ma YH, Tomlinson EE, Fairhall KM, Robinson IC. Clark RG, et al. Among authors: mortensen dl. Endocrinology. 1997 Oct;138(10):4316-23. doi: 10.1210/endo.138.10.5424. Endocrinology. 1997. PMID: 9322945

10

Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.

Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V. Clark RG, et al. Growth Regul. 1993 Mar;3(1):50-2. Growth Regul. 1993. PMID: 7683530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters